Finding a Needle in a Haystack: Take-Home Naloxone in England 2017/18

Release surveyed each of the 152 local authority areas in England, as local authorities are responsible for commissioning drug services, which give out take-home naloxone. The report includes findings on the availability of take-home naloxone across local authority areas, the scale of take-home naloxone supply in community settings, and coverage among people who use opiates and opiate clients in drug treatment.

Continue reading

Naloxone: The life-saving drug more Americans need

With over 115 Americans dying a day in the opioid epidemic, naloxone has become a necessity for first responders, doctors and everyday people. In April, in response to the national opioid crisis, the U.S. surgeon general came out with an advisory calling on more Americans to carry naloxone: elderly patients on painkillers, bartenders and librarians, mothers with addicted children and children with addicted mothers. But making naloxone accessible – getting it to those who need it – is complicated.

Continue reading

Overdoses linked to fentanyl may need multiple doses of antidote naloxone

New and more potent fentanyl may need multiple doses of the overdose antidote naloxone as deaths due to illicit versions of the opioid continue to rise, according to the Centers for Disease Control and Prevention. The agency issued a new public health alert to local health departments and related law enforcement on rising numbers of deaths related to fentanyl and similar products.

Continue reading

Concentrated naloxone nasal spray as good as injection

A new study published by the scientific journal Addiction has found that a concentrated 2mg intranasal naloxone spray delivers naloxone as effectively, over the critical first 15 minutes, as the standard 0.4mg intramuscular (IM) naloxone injection. The research was co-authored by Professor Sir John Strang and Dr Rebecca McDonald, National Addiction Centre, Institute of Psychiatry, Psychology & Neuroscience (IoPPN), King’s College London.

Continue reading

This website has been made possible through the provision of an arm length/unrestricted educational grant from Ethypharm. Ethypharm do not control and are not liable for any of the content placed, or any of the claims that may be made, on this site.

HIT